Synthesis, acid-base behavior, and binding properties of 6-modified myo-inositol 1,4,5-tris(phosphate)s

Area of Science:

• Biochemistry
• Molecular Biology
• Medicinal Chemistry

Background:

• myo-Inositol 1,4,5-tris(phosphate) (Ins(1,4,5)P(3)) is a crucial second messenger in cellular signaling.
• Ins(1,4,5)P(3) receptors play vital roles in calcium homeostasis and cellular responses.
• Understanding the structure-activity relationship of Ins(1,4,5)P(3) is key to developing targeted therapeutics.

Purpose of the Study:

• To synthesize and characterize novel analogues of myo-inositol 1,4,5-tris(phosphate) modified at the 6-position.
• To evaluate the binding affinity of these novel analogues to Ins(1,4,5)P(3) receptors.
• To elucidate the structural and electronic factors influencing the interaction between Ins(1,4,5)P(3) analogues and their receptors.

Main Methods:

• Chemical synthesis of 6-deoxy-, 6-fluoro-6-deoxy-, epi-, and 6-amino-6-deoxy-myo-inositol 1,4,5-tris(phosphate) analogues.
• Assessment of receptor binding affinity using established biochemical assays.
• Computational analysis of molecular properties, including acid-base behavior and phosphate group interactions.

Main Results:

• The synthesized 6-modified analogues demonstrated significantly reduced affinity for Ins(1,4,5)P(3) receptors compared to the parent compound.
• Specific analogues synthesized include 6-deoxy-, 6-fluoro-6-deoxy-, epi-, and 6-amino-6-deoxy-myo-inositol 1,4,5-tris(phosphate).
• Loss of affinity is potentially linked to altered intramolecular acid-base behavior and cooperative effects among the phosphate groups.

Conclusions:

• Modification at the 6-position of myo-inositol 1,4,5-tris(phosphate) drastically impairs binding to Ins(1,4,5)P(3) receptors.
• The findings highlight the critical role of the 6-position in receptor recognition and binding.
• Understanding these interactions provides insights into Ins(1,4,5)P(3) receptor function and potential drug design strategies.